SEC Form 4 · accession 0001645627-15-000006

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · 10% Owner

Period of report

Sep 16, 2015

Accepted (ET)

Oct 15, 2015 · 2:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Sep 16, 2015	P	250	$0.065	A	19,598,510	D
Common Stock	Sep 16, 2015	P	250	$0.073	A	19,598,760	D
Common Stock	Sep 17, 2015	P	200	$0.0649	A	19,598,960	D
Common Stock	Sep 17, 2015	P	300	$0.0649	A	19,599,260	D
Common Stock	Sep 22, 2015	P	200	$0.07	A	19,599	D
Common Stock	Sep 22, 2015	P	500	$0.07	A	19,599,960	D
Common Stock	Sep 22, 2015	P	1,428	$0.07	A	19,601,388	D
Common Stock	Sep 22, 2015	P	357	$0.07	A	19,601,745	D
Common Stock	Sep 23, 2015	P	285	$0.0699	A	19,602,030	D
Common Stock	Sep 23, 2015	P	100	$0.07	A	19,602,130	D
Common Stock	Sep 24, 2015	P	100	$0.07	A	19,602,230	D
Common Stock	Sep 24, 2015	P	1,000	$0.07	A	19,603,230	D
Common Stock	Sep 25, 2015	P	500	$0.07	A	19,603,730	D
Common Stock	Sep 28, 2015	P	1,000	$0.07	A	19,604,730	D
Common Stock	Sep 29, 2015	P	200	$0.07	A	19,604,930	D
Common Stock	Sep 29, 2015	P	200	$0.07	A	19,605,130	D
Common Stock	Oct 1, 2015	P	3,571	$0.07	A	19,608,701	D
Common Stock	Oct 2, 2015	P	1,000	$0.07	A	19,609,701	D
Common Stock	Oct 5, 2015	P	500	$0.07	A	19,610,201	D
Common Stock	Oct 6, 2015	P	500	$0.699	A	19,610,701	D
Common Stock	Oct 6, 2015	P	200	$0.085	A	19,610,901	D
Common Stock	Oct 12, 2015	P	100	$0.085	A	19,611,001	D
Common Stock	Oct 12, 2015	P	1,000	$0.085	A	19,612,001	D
Common Stock	Oct 13, 2015	P	200	$0.085	A	19,612,201	D
Common Stock	Oct 14, 2015	P	200	$0.0898	A	19,614,401	D
Common Stock	Oct 14, 2015	P	500	$0.10	A	19,614,901	D

No Table II lines on this filing.